1 Min Read
Oct 11 (Reuters) - ANNEXIN PHARMACEUTICALS AB (PUBL) :
* JAMAL EL-MOSLEH IS APPOINTED NEW CEO OF ANNEXIN PHARMACEUTICALS AB
* JAMAL EL-MOSLEH STARTS AS CEO ON 16 OCTOBER 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.